Purdue Pharma LP," SCOTUS struggled to decide whether or not to approve Purdue's bankruptcy settlement. The court was torn ...

The years-long class action litigation against Purdue Pharma, makers of the opioid OxyContin, got its day in front of the ...

The letter comes as OxyContin maker Purdue Pharma goes through bankruptcy and tries to settle 2,700 lawsuits over the opioid crisis… What does a $260 million settlement suggest for future opioid ...

Stacey Bridges and Creighton Bloyd, Appellants v. Purdue Pharma L.P., et al., and the United States of America, Appellees OPINION AND ORDER Stacey Bridges and Creighton Bloyd (“Appellants ...

In September 2019, Purdue Pharma filed Chapter 11 bankruptcy to seek protection from lawsuits about its opioid pain medication, OxyContin. Four years later, in December 2023, the U.S. Supreme ...

NEW YORK (Reuters) - OxyContin maker Purdue Pharma LP filed for bankruptcy protection Sunday night, succumbing to pressure from more than 2,600 lawsuits alleging the company helped fuel the deadly ...

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company’s ...

Vifor Pharma Group is a global pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The company is a partner of choice for ...

Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases.

LP-284 is the third drug candidate brought to clinical trials by Lantern Pharma using AI, machine learning and computational biology approaches. Lantern estimates that LP-284 can have the ...

The presentation of the poster titled "A Phase 1 study in healthy subjects of LP-003, a novel long-acting, high affinity anti-IgE antibody" by Longbio Pharma marked a significant moment during the ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...